FDA inspection
Biocon Biologics Limited: FDA inspection ending Aug 26, 2022
FDA inspection 1178524 · Official Action Indicated (OAI) · Bengaluru
Key facts
| Inspection ID | 1178524 |
|---|---|
| Firm | Biocon Biologics Limited |
| FEI number | 3003981475 |
| Address | B1 B2 Block No, 1st Floor; Q13 Of Q1 And W20 & Unit S18 |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2022 |
| Inspection end date | Aug 26, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data